Can you provide the last earnings date for BIODESIX INC?
BIODESIX INC (BDSX) last reported earnings on 2/26/2026.
NASDAQ:BDSX • US09075X2071
Past quarterly earnings results for BIODESIX INC (BDSX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.49 | -0.87 | 43.81% | 59.17% | 25.148M | 26.243M | -4.17% | 23.10% |
| Q3 2025 | -1.16 | -1.47 | 21.02% | 17.14% | 21.768M | 21.393M | 1.75% | 19.93% |
| Q2 2025 | -1.60 | -1.39 | -14.78% | - | 20.018M | 18.833M | 6.29% | 11.68% |
| Q1 2025 | -1.60 | -1.39 | -15.34% | 42.86% | 17.958M | 19.855M | -9.55% | 21.19% |
| Q4 2024 | -1.20 | -1.36 | 11.77% | 40.00% | 20.429M | 20.279M | 0.74% | 39.28% |
| Q3 2024 | -1.40 | -1.50 | 6.41% | 50.00% | 18.151M | 18.984M | -4.39% | 34.54% |
| Q2 2024 | -1.60 | -1.88 | 14.75% | 52.94% | 17.925M | 16.538M | 8.39% | 50.99% |
| Q1 2024 | -2.80 | -2.92 | 4.24% | 41.67% | 14.818M | 14.464M | 2.45% | 63.63% |
| Q4 2023 | -2.00 | -2.24 | 10.87% | 71.43% | 14.668M | 15.919M | -7.86% | 52.63% |
| Q3 2023 | -2.80 | -3.06 | 8.50% | 58.82% | 13.491M | 14.647M | -7.89% | 21.43% |
| Q2 2023 | -3.40 | -4.22 | 19.36% | 57.50% | 11.872M | 11.905M | -0.28% | 8.42% |
| Q1 2023 | -4.80 | -4.83 | 0.58% | 52.00% | 9.056M | 8.891M | 1.86% | 38.26% |
| Q4 2022 | -7.00 | -5.66 | -23.65% | 28.57% | 9.61M | 10.987M | -12.53% | 33.10% |
| Q3 2022 | -6.80 | -6.68 | -1.78% | 17.07% | 11.11M | 10.37M | 7.14% | 70.14% |
| Q2 2022 | -8.00 | -9.49 | 15.67% | 2.44% | 10.95M | 8.995M | 21.73% | -7.91% |
| Q1 2022 | -10.00 | -8.23 | -21.54% | -117.39% | 6.55M | 6.596M | -0.70% | -77.31% |
| Q4 2021 | -9.80 | -10.00 | 1.96% | -96.00% | 7.22M | 7.684M | -6.04% | -73.29% |
| Q3 2021 | -8.20 | -9.74 | 15.82% | 98.72% | 6.53M | 6.298M | 3.68% | -28.94% |
| Q2 2021 | -8.20 | -5.85 | -40.22% | - | 11.89M | 21.565M | -44.86% | 27.37% |
| Q1 2021 | -4.60 | -3.57 | -28.85% | - | 28.87M | 26.774M | 7.83% | - |
| Q4 2020 | -5.00 | -8.98 | 44.30% | - | 27.03M | 15.761M | 71.50% | - |
| Q3 2020 | -638.60 | -138.41 | -361.37% | - | 9.19M | 8.63M | 6.49% | - |
| Q2 2020 | - | - | 9.335M | - | - |
Notes
BIODESIX INC (BDSX) last reported earnings on 2/26/2026.
BIODESIX INC (BDSX) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, BIODESIX INC (BDSX) has beaten EPS estimates in 2 out of 4 releases.